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INTRODUCTION
Owing to the progressively increasing frequency of hospital-acquired Gram-negative infections (Finland, 1970) Nowotny, Radvany & Neale (1965) first reported that certain activities may be neutralized in vitro with homologous hyperimmune antisera against heat-killed bacteria. These activities included Shwartzman skin reactivity, pyrogenicity, and animal lethality; however, the nonspecific, resistance-enhancing effect of the endotoxins was not affected. Hyperimmune serum was later shown to contain immunoglobulins specific for the toxic moiety of the endotoxin . Similar effects of anti-smooth endotoxin serum were reported by Tate, Douglas & Braude (1966) , by Berczi (1967) and by Greisman, Young & DuBuy (1973) . The last-mentioned study showed that the antisera neutralized the pyrogenicity of the homologous endotoxins but not that of heterologous preparations.
Emphasis has therefore been placed on developing antigens capable of eliciting crossreactive, neutralizing antibodies, in an attempt to provide protection against a wide range of Enterobacteriaceae. Kunin (I 963) described a common antigen in Enterobacteriaceae and the antibody to this shared antigen opsonized heterologous Gram-negative bacilli for phagocytosis (Domingue & Neter, I 966). However, passively administered rabbit antisera to this common antigen failed to protect mice against Gram-negative bacterial infections (McCabe & Greely, 1973) .
Another potential protective antigen of Enterobacteriaceae is the lipid moiety of lipopolysaccharide (LPS) which is believed to have a similar structure in different Gramnegative bacteria and to constitute the toxic site of the LPS (Luderitz et al., 1973) . Accordingly, it might be expected that antiserum against the lipid A might neutralize endotoxins from a broad spectrum of Gram-negative bacteria and/or facilitate their removal by opsonization. Such antisera have been prepared by immunizing animals either against rough mutants or 'lipid A' preparations made by partial acid hydrolysis of LPS (Rank, Dipaul & Flugge-Rank, 1972; Galanos, Luderitz & Westphal, 1971 ; Rietschel et al., 1973) . Studies by Chedid et al. (1968) showed that horse hyperimmune serum against rough Salmonella typhinturium protected mice against infections with pathogenic Klebsiella pneumoniae, McCabe (1972) also reported that active and passive immunization with rough Rd2 and Re mutants of S. minnesota offered significant protection against challenge with K. pneumoniae and Escherichia coli. More recently, Ziegler et ul. (1973) showed that antiserum against a UDP-Gal epimerase-deficient mutant (Rc) of E. coli prevented lethal bacteraemia from pathogenic E. coli and K . pneumoniae in agranulocytic animals. All the above studies suggested the presence of common antigenic sites in the basal core of the LPS. More specifically, Galanos et al. (1971) prepared antibodies to 'lipid A' by using ' lipid A'-coated, acid-hydrolysed S. minnesota R595, and showed that anti-' lipid A' antibodies sensitized E. coli for intraperitoneal phagocytosis. However, recent studies by Mullan et al. (1974) have discounted any beneficial role of these antibodies in protection against Gram-negative infections in mice.
Our earlier in vitro studies (Ng et al., 1974) showed that anti-S. minnesota R595 serum cross-reacted with S. minnesota R595 and S. typhimurium SLI 102 Re glycolipids. The same serum neutralized the endotoxicity not only of these two glycolipids, but of LPS from smooth S. minnesota as well. In the present study, antisera were prepared against two Re mutants, S. minnesota R595 and S. typhimurium ~~1 1 0 2 .
The antisera were first tested for their serological cross-reactivities against various E. coli Re mutants and endotoxin preparations from other strains. In later experiments the antisera were tested against experimental infections with K . pneumoniae type 11, S. typhi 0901, a bacteraemia isolate of E. coli, and P. aeruginosa I I 9. While the findings reported here indicate serological cross-reactivity between the Re mutants in vitro, passive transfer of such sera to normal animals did not protect them against lethal challenges with the above bacterial strains. were gifts from Dr H. Boman of the University of Umea, Umea, Sweden. The bacteria were cultivated in a broth culture medium on a large scale in a fermenter, as previously described for S. minnesota R595 (Kasai & Nowotny, 1967) .
M E T H O D S
The four Gram-negative bacteria used for challenge in mouse protection tests were Isolation of glycolipids. Endotoxic glycolipids of the mutants were prepared as described previously (Ng et al., 1974) by direct extraction of lyophilized cells with chloroformmethanol (4 : I, v/v). The crude preparations were purified by precipitation with chloroformmethanol (I : 2, v/v). Glycolipids were also prepared from S. minnesota ~5 9 5 cells by the phenol-water extraction method (Luderitz et al., I 966) and the phenol-chloroformpetroleum ether procedure (Galanos, Luderitz & Westphal, I 969) .
Preparation of RESI from bacterial lipopolysaccharides. Endotoxic lipopolysaccharides were isolated from lyophilized cells of Serratia marcescens, E. coli 0127 and P. Jluorescens, using the trichloroacetic acid extraction procedure of Boivin, Mesrobeanu & Mesrobeanu (I 933). The preparations were further purified by the phenol-water procedure, and the products were precipitated by methanol and redissolved and sedimented by ultracentrifugation, as described previously . 'Lipid A' precipitate was obtained Immunization. Antisera against S. minnesota R595 and S. typhimurium SLI I 02 heat-killed cells were prepared as described previously (Ng et al., 1974) . In the preparation of antisera against purified glycolipids from S. rninnesota R595 cells, the chloroform-methanol (4 : I)-soluble glycolipids were coated on autologous erythrocytes of New Zealand white rabbits. For the coating procedure, the same method was applied as described earlier for coating erythrocytes for passive haemagglutination, with the following minor modifications. About 10 ml of blood was drawn from each rabbit 2 days before immunization. It was divided into two 5 ml portions, each of which was mixed with 0.7 ml acid-citrate-dextrose anticoagulant solution and stored at cold-room temperature. On the day before immunization, the preserved blood was washed with saline (0.9 % NaC1) three times. After the final wash, the blood cells were centrifuged and 5 ml of S. minnesota R595 glycolipid suspension was added to the packed erythrocyte sediment. The chloroform-methanol (4 : I)-soluble glycolipid suspension (I mg ml-l), prepared by sonicating the glycolipid in saline, was preheated in a boiling water bath for 2 h. The cell suspension and the cooled glycolipid were incubated under constant rotation at 37 "C for I h and overnight at 4 "C. The mixture was then washed twice with saline and the coating of glycolipid on red cells was verified by the passive haemagglutination test using antiserum against S. minnesota R595 of known titre. Finally, the coated red cells were sedimented and resuspended in 4 vol. saline. This suspension was used for injection for three consecutive days. Since six injections were given altogether, a new batch of red blood cells was prepared the day before the second series of immunization injections. Each rabbit was injected with 0.5 ml of glycolipid-coated red blood cell suspension on days I , 2, 3, 8, 9 and 10. All animals were exsanguinated 2 1 days after the first injection. Serological procedures. Passive haemagglutination, passive haemagglutination inhibition and double gel diffusion were performed as previously described (Nowotny, 1969) .
Mouse protection tests. The challenging bacteria [K. pneumoniae type 11, S. typhi 0901, P. avruginosa 119 and E. coli (isolated from a bacteraemia patient)] were maintained on Trypticase soy agar slants. Overnight cultures of the organisms in brain-heart infusion broth were centrifuged and washed three times in saline (0.9% NaCl) and resuspended again in saline. Serial dilutions were made from this suspension and viable counts made on agar plates. Female ICR mice (8 to 10 weeks old) were injected intravenously with 0.2 ml of culture and the LD,, determined as already described (Nowotny, 1969) . In the passive protection experiments, the antiserum was given intravenously in a volume of 0.2 ml, I h before challenge with I, 2 or 5 LD, of bacteria.
Challenge of mice with opsonized bacteria. Bacterial suspensions prepared as described above were added to normal or immune rabbit serum. To 2 vol. of bacterial cell suspension were added 3 vol. of sterile immune or normal rabbit serum and the suspensions maintained at room temperature with constant rotation for I h. Before injection, the viable counts of bacterial cells in the suspensions were estimated, again by the agar plate count technique.
RESULTS

Immunization with bacteria and with Re glycolipid-coated autologous erythrocytes
We had previously found that isolated glycolipid preparations were non-immunogenic in rabbits, and also that antisera raised against whole Re mutant cells were not specific to the glycolipids of the cells only but contained antibodies against other cell wall components (unpublished data). Accordingly, rabbits were immunized with purified S. minnesota ~5 9 5 glycolipid coated on autologous erythrocytes, as described above. As shown in Table I , this new procedure gave rise to a low but significant antibody level.
Immunization with whole Re mutant cells of S. rninnesota ~5 9 5 and S. typhimurium S L I I O~ gave a somewhat higher titre to isolated glycolipid than immunization with glycolipid coated autologous erythrocytes. The antiserum titres determined by passive haemagglutination ranged from 64 to 256 (Table I) . Table I .
f Antiserum was absorbed with an equal volume of glycolipid suspension (I mglml) for 30 min at 37 "C followed by I h at 4 "C. 
Cross-reactivity of the antisera
In the passive haemagglutination test, shown in Table I , it was also evident that the rabbit anti-Re cell sera cross-reacted with both S. minnesota R595 and S. typhimurium S L I I O~ glycolipids. In addition, the two antisera also cross-reacted with the glycolipids extracted from the three E. coli Re mutants, E. coli ~5 1 5 , E. coli ~3 1 m 4 and E. coli D 2 I f 2 , as demonstrated again by passive haemagglutination ( Table 2 ). The specificity of the anti-S. minnesota ~5 9 5 serum was tested by absorption with S. minnesota R595 glycolipid. This absorption completely removed antibody to all five glycolipids ( Table 2) .
The cross-reactivity among the various glycolipids was more conclusively demonstrated by gel diffusion. As shown in Fig. I (a) and (b) both the above antisera formed reactions of identity with glycolipids from all five Re mutants.
The two antisera were also tested against S. minnesota R595 endotoxins prepared by the three different extraction procedures described in Methods. Both anti-S. minnesota ~5 9 5 and anti-S. typhimurium SLI 102 cross-reacted with all three preparations, again giving lines sndicating antigenic identity (Fig. 2) .
The antiserum prepared by injecting glycolipid-coated autologous erythrocytes, which is more specific than antisera obtained by immunization with whole Re cells, also cross-reacted with the three E. coli Re glycolipids. Table 2 shows the results of passive haemagglutination and Fig. I (c) shows the patterns of gel diffusion. In the latter, the precipitation lines again show antigenic identity.
Antibodies to the lipid moiety of endotoxins 1 1 3 * Mice in groups of ten were given 0.2 ml of saline or sera intravenously I h before challenge.
-f Challenge organisms were introduced intravenously in 0.2 ml volume. Survival was estimated at 48 h 2 The antisera were mixed in equal volume.
in all cases except for K. pneumoniae type I1 where it was estimated at 4th day. In the gel diffusion test, the anti-S. minnesota R595 and S. typhimurium S L I I O~ antisera were also tested for their ability to cross-react with various RESI preparations. As shown in Fig. 3 , both antisera cross-reacted with RESI preparations from LPS of E. coli 0127, P. JEuorescens and Serratia marcescens.
Attempts at passive protection of mice with immune sera As a result of the above observations that antisera against Re mutant cells, or Re glycolipid, cross-reacted with endotoxic components from various Gram-negative bacteria, tests were made to see if the antisera would protect mice against Gram-negative infections. Four strains of Gram-negative bacteria, K. pneumoniae type 11, S. typhi 0901, P . aeruginosa I 19 and an E. coli strain, were used for challenging passively immunized and untreated animals. The LD,, for the four bacteria was determined as 1.5 x 103, 5.0 x I O~, 1.0 x 107 and 8.0 x 10' cells, respectively. No protective effect of anti-S. minnesota R595 (titre 256) and anti-S. typhimurium S L I I O~ (titre 256) sera in mice challenged with I, 2 or 5 LDso of the challenge bacteria was observed ( Table 3) .
8-2
Injection of antibody-coated bacteria into mice The above antisera were used to pre-coat the bacterial challenge suspensions before injection into mice. The results in Table 4 compare survival of mice challenged with bacteria incubated either in antiserum, in normal serum or in saline. In these experiments, P. aeruginosa 119 was used and all three antisera described above were added to either I or 5 LD,, challenge doses. Using the I LD,, challenge dose, anti-S. typhimurium ~~1 1 0 2 seemed to increase the survival rate of animals slightly, although the results are not statistically significant. Anti-S. minnesota ~5 9 5 and anti-glycolipid (on autologous erythrocyte) antisera showed similar results to normal serum. When the challenge dose was increased to 5 LD,,, all experimental animals died.
DISCUSSION
While isolated glycolipid injected into rabbits showed no detectable antibody production the same material proved to be immunogenic when coated on rabbit autologous red blood cells (Tables I and 2, Fig. I c) . This indicates that at least some of the immunodeterminants present in a glycolipid molecule are sufficiently exposed to manifest immunogenicity when coated on to red blood cells. This antiserum, as compared with antisera elicited by the injection of glycolipid-containing whole cells, is specific for the glycolipid molecule only, since nothing else foreign has been injected. Such antiserum may find several uses, such as in the investigation of the exposure of the lipid moiety of LPS on bacterial surfaces, or in studying the role of antibodies specific against the lipid moiety in host resistance against infection, as will be discussed later. The immunization procedure developed may also be generally applicable in raising specific antibody to any antigenic but not immunogenic compounds that bind to autologous erythrocytes of animals used for immunization.
The aim of the studies reported here was twofold. First, we wished to investigate the existence of cross-reacting immunodeterminants in a variety of Gram-negative bacterial endotoxins. Secondly, and more important, we wished to see what role immunoglobulins, directed against certain immunodeterminants present in the lipid moiety of Gram-negative endotoxins, may have in host resistance against Gram-negative infections.
In a previous study (Ng et al., I 974), we used the passive haemagglutination and Ouchterlony tests to demonstrate cross-reactivity and immunological identity between Re glycolipids from S. rninnesota ~5 9 5 and S. typhimurium S L I I O~. An earlier report by Schmidt, Jann & Jann (1970) showed cross-reactivity between the Re glycolipids from S. minnesota ~5 9 5 and E. coZi F S I~ by the passive haemagglutination method. In the present study we found serological cross-reactivity among the above two Salmonella Re glycolipids and three Re glycolipids from E. coli ~5 I 5, E. coli D3 I m4 and E. coli D2 I f2 by the same methods (Tables I and 2, Fig. I) . The antisera which cross-reacted with the five Re glycolipids were anti-S. minnesota R595 and anti-S. typhimurium SLI 102 sera as well as antiserum prepared against purified S. rninnesota R595 glycolipid coated on autologous red blood cells of rabbits. As Fig. I shows, one major gel diffusion precipitin band is shared by all preparations tested. On the other hand, certain antisera formed additional precipitin bands with a few glycolipid preparations. This seems to indicate that not all immunodeterminants present in these glycolipids are equally shared by all preparations tested.
The results discussed above were obtained by using glycolipids extracted from heptoseless Re mutants of Gram-negative bacteria which synthesize only the lipid moiety of endotoxic lipopolysaccharide of parental strains. Chang & Nowotny (I 979, attempted to obtain partially degraded fractions of smooth endotoxic lipopolysaccharide, devoid of polysaccharide but still maintaining characteristic endotoxic reactions. Such material was isolated from smooth lipopolysaccharides of Ser. marcescens, E. coli 0127 and P. fluorescens. The preparation, called RESI, was fully active in a number of endotoxicity parameters. In the present studies, cross-reactivity among the above three RESI preparations with anti-S. minnesota ~5 9 5 and anti-S. typhimurium SLI 102 was determined. The results (Fig. 3) showed that such RESI preparations, which seem to represent the most essential core of the active site of endotoxin molecules, also carry immunodeterminants present in Re glycolipid, synthesized by defective mutant strains. This indicates that the smooth LPS molecule may be reduced by chemical procedures to a greatly simplified and yet highly endotoxic fragment. At least one immunodeterminant present in this fragment seems to be present in a number of unrelated Gram-negative smooth or rough endotoxins.
The above findings, which showed that there is a cross-reactive antigenic site(s) in the lipid moiety of LPS, prompted us to investigate the possible beneficial role of antibodies directed at the lipid moiety of LPS in animal immunity to bacterial infections. Disappointingly enough, in the present studies repeated attempts to protect mice against Gram-negative bacterial infections with antisera against Re mutants such as S. minnesota R595 and S. typhimurium SLI 102 and antiserum against purified S. minnesota R 5 9 5 glycolipid failed (Tables 3 and 4) .
The discrepancy observed in our results and those of others 
